- Home
- RYTM vs ACT Comparison
RYTM vs ACT Comparison
Compare RYTM & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- ACT
- Stock Information
- Founded
- RYTM 2008
- ACT 1981
- Country
- RYTM United States
- ACT United States
- Employees
- RYTM N/A
- ACT N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- ACT Specialty Insurers
- Sector
- RYTM Health Care
- ACT Finance
- Exchange
- RYTM Nasdaq
- ACT Nasdaq
- Market Cap
- RYTM 6.4B
- ACT 5.5B
- IPO Year
- RYTM 2017
- ACT 2021
- Fundamental
- Price
- RYTM $96.03
- ACT $38.22
- Analyst Decision
- RYTM Strong Buy
- ACT Hold
- Analyst Count
- RYTM 13
- ACT 3
- Target Price
- RYTM $101.92
- ACT $39.67
- AVG Volume (30 Days)
- RYTM 553.4K
- ACT 314.2K
- Earning Date
- RYTM 11-04-2025
- ACT 11-05-2025
- Dividend Yield
- RYTM N/A
- ACT 2.16%
- EPS Growth
- RYTM N/A
- ACT 6.06
- EPS
- RYTM N/A
- ACT 4.41
- Revenue
- RYTM $156,287,000.00
- ACT $1,223,030,000.00
- Revenue This Year
- RYTM $44.69
- ACT $4.10
- Revenue Next Year
- RYTM $63.53
- ACT $3.52
- P/E Ratio
- RYTM N/A
- ACT $8.82
- Revenue Growth
- RYTM 53.55
- ACT 3.15
- 52 Week Low
- RYTM $45.91
- ACT $30.79
- 52 Week High
- RYTM $106.52
- ACT $39.47
- Technical
- Relative Strength Index (RSI)
- RYTM 46.64
- ACT 53.65
- Support Level
- RYTM $97.47
- ACT $38.12
- Resistance Level
- RYTM $102.46
- ACT $39.47
- Average True Range (ATR)
- RYTM 3.22
- ACT 0.69
- MACD
- RYTM -1.44
- ACT -0.02
- Stochastic Oscillator
- RYTM 13.52
- ACT 50.79
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About ACT Enact Holdings Inc.
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The principal mortgage insurance customers are originators of residential mortgage loans who determine which mortgage insurer or insurers will be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.